GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) » Definitions » Other Current Receivables

Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Other Current Receivables : ¥230 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Shanghai Kaibao Pharmaceutical Co Other Current Receivables?

Shanghai Kaibao Pharmaceutical Co's Other Current Receivables for the quarter that ended in Mar. 2024 was ¥230 Mil.

Shanghai Kaibao Pharmaceutical Co's quarterly Other Current Receivables declined from Sep. 2023 (¥279.76 Mil) to Dec. 2023 (¥159.37 Mil) but then increased from Dec. 2023 (¥159.37 Mil) to Mar. 2024 (¥230.30 Mil).

Shanghai Kaibao Pharmaceutical Co's annual Other Current Receivables declined from Dec. 2021 (¥268.38 Mil) to Dec. 2022 (¥191.42 Mil) and declined from Dec. 2022 (¥191.42 Mil) to Dec. 2023 (¥159.37 Mil).


Shanghai Kaibao Pharmaceutical Co Other Current Receivables Historical Data

The historical data trend for Shanghai Kaibao Pharmaceutical Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kaibao Pharmaceutical Co Other Current Receivables Chart

Shanghai Kaibao Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 275.57 241.53 268.38 191.42 159.37

Shanghai Kaibao Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 279.54 318.01 279.76 159.37 230.30

Shanghai Kaibao Pharmaceutical Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Shanghai Kaibao Pharmaceutical Co Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Shanghai Kaibao Pharmaceutical Co's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Business Description

Traded in Other Exchanges
N/A
Address
88 Chengpu Road, Shanghai Industrial Comprehensive Development Zone, Shanghai, CHN, 201401
Shanghai Kaibao Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in research, development, production, and sales of modern Chinese medicine. The company produces traditional Chinese medicines in the form of solid dosage, oral liquids, and small volume injections. Its main product is Tanreqing injection is mainly used for pneumonia, acute and chronic bronchitis and upper respiratory tract infection.
Executives
Liu Shao Yong Supervisors
Ren Li Wang Secretary Dong
Zhang Tao Executives
Mu Jing Wei Director
Li Xiu Hai Directors, executives
Zhang Lian Xin Supervisors
Han Jing Independent director
Wang Guo Ming Directors, executives
Wang Chong Bang Executives
Liu Yi Shan Director
Li Qing Wei Independent director
Mu Lai An Director
Zhu Ying Jun Executives
Chang Qing Ling Supervisors
Zhang Peng Director

Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Headlines

No Headlines